Drug intelligence / Profile preview

fenoldopam

Development stage
Phase 4
Lead developer
Pfizer
Modality
Classical Binding Small Molecules → Small Molecules
Administration
Intravenous
01

Overview

Fenoldopam is a synthetic benzazepine derivative and selective dopamine D1 receptor agonist used as a rapid-acting, short-term intravenous antihypertensive agent. It lowers blood pressure by causing arteriolar vasodilation, primarily through activation of peripheral D1-like dopamine receptors, with minimal adrenergic effects. Fenoldopam increases renal blood flow and promotes natriuresis and diuresis, making it particularly useful in hypertensive emergencies or when rapid blood pressure reduction is required in hospital settings. The drug has no significant affinity for D2-like receptors or beta-adrenoceptors but binds with moderate affinity to alpha2-adrenoceptors. Its onset of action is within minutes and duration is less than 10 minutes after infusion stops[1][2][5][8].

Brand names
Corlopam
Other names
fenoldopamumfénoldopam
02

Targets

DRD1 (Dopamine D1 Receptor)ADRA2A (α2A)

Beyond the preview

Go deeper on fenoldopam.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fenoldopam.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call